Get complete access to comprehensive company data for Novartis India Limited.
Complete Report
One-time • Full access
Credit Plan
Pay as you go • Instant
Processing your request...
Downloading your report...
Success
Request Company Screening
Novartis India Limited
Once your screening request is processed, you will receive a notification and the complete report will be available in PDF format for download from your account dashboard.
₹ 32.00 cr
₹ 12.35 cr
13 Dec 1947
31 Mar 2024
Novartis India Limited is an Indian public limited company incorporated on 13 Dec 1947. The company's registered office is situated in Mumbai, Maharashtra, India.
The current status of Novartis India Limited is Active. The company has filed its annual returns and financial statements up to 31 Mar 2024 (FY 2023-2024).
Novartis India Limited is a company limited by shares with an authorized capital of ₹32.00 cr and a paid-up capital of ₹12.35 cr as per the records maintained by the Ministry of Corporate Affairs (MCA).
Novartis India Limited has 6 directors and 2 signatories. The Key Managerial Personnel (KMP) at Novartis India Limited include Chandni Bhupendra Maru as Company Secretary and Shilpa Shashank Joshi as CFO. The directors of the company include Sanker Parameswaran, Sandra Martyres, Gira Jagdeesh Sardesai, Christopher David Snook.
The registered office of Novartis India Limited is located at Inspire Bkc 7Th Floor Bandra Kurla Complex Bandra East Bandra Maharashtra 400051 India in Mumbai, Maharashtra, India.
- CIN/LLPIN/FCRN: L24200MH1947PLC006104
- Legal Name: Novartis India Limited
- ROC Code: Roc Mumbai
- Company No.: 006104
- Company Category: Company Limited By Shares
- Company Sub Category: Non-Government Company
- Company Class: Public
- Listing Status: Listed
- Industry: Pharma
- Date of AGM: 31 Jul 2024
🔒 14.3%
(FY 202_)🔒 8.9%
(FY 202_)🔒 12.7%
(FY 202_)🔒 9.5%
(FY 202_)🔒 11.8%
(FY 202_)🔒 15.2%
(FY 202_)🔒 10.6%
(FY 202_)🔒 13.4%
(FY 202_)
Financial Performance Overview
| Financial Metric | FY 2023 | Growth | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | 12,45,67,890 | +191.42% | 4,26,78,123 | 3,89,45,234 | 2,98,12,456 | 2,15,67,890 |
| Revenue from Operations | 11,98,45,678 | +176.82% | 4,32,10,987 | 3,78,90,123 | 2,89,45,678 | 2,10,23,456 |
| Total Assets | 45,67,89,012 | +61.07% | 28,34,56,789 | 24,56,78,901 | 19,87,65,432 | 16,54,32,109 |
| Profit or Loss | -1,23,45,678 | 24.56% | 4,32,109 | 2,15,678 | 1,89,234 | 1,23,456 |
| Net Worth | 12,34,56,789 | 85.66% | 85,67,89,012 | 78,90,12,345 | 65,43,21,098 | 54,32,10,987 |
| EBITDA | 2,34,56,789 | +6604.87% | 3,49,012 | 2,10,987 | 1,56,789 | 98,765 |
| Past Director Details of Novartis India Limited |
|---|
Frequently Asked Questions
- chandni bhupendra maru
- christopher david snook
- falin ishwarlal majmudar
- gira jagdeesh sardesai
- sandra martyres
- sanker parameswaran
- shilpa shashank joshi
- shilpa shashank joshi